Eubiotics的全球市場 - 成長性，趨勢，未來預測

本報告以Eubiotics的全球市場為研究主題，提供市場成長的推動要素，阻礙因素，市場機會，以及依據市場競爭情形廣泛調查的現行市場分析與未來預測。

第1章 序論

• 調查手法
• 市場定義
• 本報告

第2章 重要的調查結果

第3章 市場概要

• 市場成長的推動要素
• 阻礙市場成長要素
• 市場機會
• 波特的五力分析

第4章 市場分類

• 各類型
  • 益生菌
  • 益生元
  • 有機酸
  • 精油
• 各動物類型
  • 反芻動物
  • 家禽
  • 豬
  • 水產養殖
  • 寵物食品
  • 馬
  • 其他
• 各地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
    • 其他
  • 歐洲
    • 西班牙
    • 英國
    • 法國
    • 德國
    • 俄羅斯
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 泰國
    • 越南
    • 澳洲
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 非洲
    • 南非
    • 埃及
    • 其他

第5章 市場競爭情形

• 市場佔有率分析
• 主要企業最大量採用的策略性方法
• 過去5年最活躍的企業

第6章 主要企業簡介

第7章 附錄

The eubiotics market is projected to register a CAGR of 7.4% during the forecast period. Eubiotics are expected to be the essential feed additive, which fills the vacuum created by the antibiotics ban. The capitalization of this vacuum is critical in the success of eubiotics, as antibiotics, irrespective of their health or environmental hazards, provided important functionality to the meat production processes. This impact is further strengthened by the systemic mode of action of eubiotics instead of a constricted local impact. The increasing production capabilities and commercialization of farming in various emerging countries are pushing the growth of the eubiotics market.

Key Market Trends

Industrialization of the Livestock Industry

The livestock sector has seen significant changes in the last decade. The surge in demand has been fulfilled by commercial livestock production and their associated value chains. In many markets, such as China, Japan, and India, animal husbandry has transformed into a highly diversified activity, with increased emphasis on scientific management of farm animals, improving productivity, and saving costs. According to the World Bank, the adoption of industrialized meat production is growing six times faster than that of traditional meat production. With an increase in the mass production of meat, the trend of landless meat production facilities is catching up. Large-scale meat production can lead to high water consumption with soil and water contamination. An estimated 60-90% of nitrogen and phosphorous consumed by animals act as a pollutant in the form of animal waste. Enhancing digestibility of feed is one of the most important functions performed by eubiotics, which help absorb these nutrients into animal tissues, thereby reducing animal waste. By helping to improve body mass of meat animals, as well as by nominally reducing the environmental impact of livestock rearing, the usage of eubiotics is expected to increase, because of the increased industrialization of livestock rearing.

Increasing Eubiotics Consumption in the United States

In terms of value, the United States accounts for more than half of the North American eubiotics market. Beef, poultry, and veal are the most commonly consumed meat in the region.The ban of antibiotics by the Food and Drug Administration (FDA) in the United States in 2017 and subsequent development of research programs by local and global players are the major factors driving the growth of the market. In addition, governing bodies of the region are adopting alternative healthy initiatives for the development of high-quality, efficient, and safer feed additives. The United States is a well-established market with the presence of strong demand for organic meat, which has compelled farmers to use natural ingredients in livestock feed. This is further expected to drive the demand for eubiotics in animal feed in the country.

Competitive Landscape

The eubiotics market is concentrated in the Asia-Pacific and North American regions and is fragmented among small regional players. Leading companies are focused on acquiring feed mills and small manufacturers are expanding the business in local, as well as foreign markets. Some of the players have been expanding their geographical presence by acquiring or merging with the manufacturers in the foreign markets. For instance, Lallemand NZ Ltd, in 2016, merged with Nutritech International to become New Zealand's largest supplier of animal nutrition and forage additive technologies. This strengthened its position in the eubiotics market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
• 4.3 Market Restraints
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Bargaining Power of Suppliers
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Threat of New Entrants
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Type
  • 5.1.1 Probiotics
    • 5.1.1.1 Lactobacilli
    • 5.1.1.2 Bifidobacteria
    • 5.1.1.3 Other Probiotics
  • 5.1.2 Prebiotics
    • 5.1.2.1 Inulin
    • 5.1.2.2 Fructo-oligosaccharides
    • 5.1.2.3 Galacto-oligosaccharides
    • 5.1.2.4 Other Prebiotics
  • 5.1.3 Organic Acids
  • 5.1.4 Essential Oils
• 5.2 By Animal Type
  • 5.2.1 Ruminant
  • 5.2.2 Poultry
  • 5.2.3 Swine
  • 5.2.4 Aquaculture
  • 5.2.5 Other Animal Types
• 5.3 By Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.1.4 Rest of North America
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Spain
    • 5.3.2.5 Russia
    • 5.3.2.6 Italy
    • 5.3.2.7 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 Rest of Asia-Pacific
  • 5.3.4 South America
    • 5.3.4.1 Brazil
    • 5.3.4.2 Argentina
    • 5.3.4.3 Rest of South America
  • 5.3.5 Middle East & Africa
    • 5.3.5.1 South Africa
    • 5.3.5.2 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Most Adopted Strategies
• 6.2 Market Share Analysis
• 6.3 Company Profiles
  • 6.3.1 BASF SE
  • 6.3.2 Cargill Incorporated
  • 6.3.3 Novozymes
  • 6.3.4 E. I. du Pont de Nemours and Company
  • 6.3.5 Kemin Industries Inc.
  • 6.3.6 Lallemand Inc.
  • 6.3.7 Koninklijke DSM NV
  • 6.3.8 Chr. Hansen Holding AS
  • 6.3.9 Addcon
  • 6.3.10 Novus International Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS